Literature DB >> 22095639

The acute effects of changes to AV delay on BP and stroke volume: potential implications for design of pacemaker optimization protocols.

Charlotte H Manisty1, Ali Al-Hussaini, Beth Unsworth, Resham Baruah, Punam A Pabari, Jamil Mayet, Alun D Hughes, Zachary I Whinnett, Darrel P Francis.   

Abstract

BACKGROUND: The AV delay optimization of biventricular pacemakers (cardiac resynchronization therapy) may maximize hemodynamic benefit but consumes specialist time to conduct echocardiographically. Noninvasive BP monitoring is a potentially automatable alternative, but it is unknown whether it gives the same information and similar precision (signal/noise ratio). Moreover, the immediate BP increment on optimization has been reported to decay away: it is unclear whether this is the result of an (undesirable) decrease in stroke volume or a (desirable) compensatory relief of peripheral vasoconstriction. METHODS AND
RESULTS: To discriminate between these alternative mechanisms, we measured simultaneous beat-to-beat stroke volume (flow) using Doppler echocardiography, and BP using finger photoplethysmography, during and after AV delay changes from 40 to 120 ms in 19 subjects with cardiac pacemakers. BP and stroke volume both increased immediately (P<0.001, within 1 heartbeat). BP showed a clear decline a few seconds later (average rate, -0.65 mm Hg/beat; r=0.95 [95% CI, 0.86-0.98]); in contrast, stroke volume did not decline (P=0.87). The immediate BP increment correlated strongly with the stroke volume increment (r=0.74, P<0.001). The signal/noise ratio was 3-fold better for BP than stroke volume (6.8±3.5 versus 2.3±1.4; P<0.001).
CONCLUSIONS: Improving AV delay immediately increases BP, but the effect begins to decay within a few seconds. Reassuringly, this is because of compensatory vasodilatation rather than reduction in cardiac function. Pacemaker optimization will never be reliable unless there is an adequate signal/noise ratio. Using BP rather than Doppler minimizes noise. The early phase (before vascular compensation) has the richest signal lode.

Entities:  

Mesh:

Year:  2011        PMID: 22095639      PMCID: PMC3378486          DOI: 10.1161/CIRCEP.111.964205

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  29 in total

1.  Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.

Authors:  Angelo Auricchio; Christoph Stellbrink; Stefan Sack; Michael Block; Jürgen Vogt; Patricia Bakker; Christof Huth; Friedrich Schöndube; Ulrich Wolfhard; Dirk Böcker; Olaf Krahnefeld; Hans Kirkels
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

2.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).

Authors:  Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Z Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

3.  Immediate and chronic effects of AV-delay optimization in patients with cardiac resynchronization therapy.

Authors:  Stefan E Hardt; Said Hashem Fani Yazdi; Alexander Bauer; Arthur Filusch; Grigorios Korosoglou; Alexander Hansen; Raffi Bekeredjian; Philipp Ehlermann; Andrew Remppis; Hugo A Katus; Helmut F Kuecherer
Journal:  Int J Cardiol       Date:  2006-08-07       Impact factor: 4.164

4.  Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay.

Authors:  Z I Whinnett; J E R Davies; K Willson; C H Manisty; A W Chow; R A Foale; D Wyn Davies; A D Hughes; J Mayet; D P Francis
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

5.  Impedance cardiography for atrioventricular interval optimization during permanent left ventricular pacing.

Authors:  Hung-Fat Tse; Cannas Yu; Euljoon Park; Chu-Pak Lau
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

6.  Invasive v. non-invasive measurement of arterial pressure. Comparison of two automatic methods and simultaneously measured direct intra-arterial pressure.

Authors:  J van Egmond; M Hasenbos; J F Crul
Journal:  Br J Anaesth       Date:  1985-04       Impact factor: 9.166

7.  Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy.

Authors:  Jeffrey E Kerlan; Navinder S Sawhney; Alan D Waggoner; Mohit K Chawla; Sanjeev Garhwal; Judy L Osborn; Mitchell N Faddis
Journal:  Heart Rhythm       Date:  2006-02       Impact factor: 6.343

8.  Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy.

Authors:  Navinder S Sawhney; Alan D Waggoner; Sanjeev Garhwal; Mohit K Chawla; Judy Osborn; Mitchell N Faddis
Journal:  Heart Rhythm       Date:  2004-11       Impact factor: 6.343

9.  Comparison of different approaches for optimization of atrioventricular and interventricular delay in biventricular pacing.

Authors:  Michel Zuber; Stefan Toggweiler; Markus Roos; Richard Kobza; Peiman Jamshidi; Paul Erne
Journal:  Europace       Date:  2008-01-29       Impact factor: 5.214

10.  The atrioventricular delay of cardiac resynchronization can be optimized hemodynamically during exercise and predicted from resting measurements.

Authors:  Zachary I Whinnett; Cathy Briscoe; Justin E R Davies; Keith Willson; Charlotte H Manisty; D Wyn Davies; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Darrel P Francis
Journal:  Heart Rhythm       Date:  2007-12-04       Impact factor: 6.343

View more
  14 in total

1.  Effects of AV-delay optimization on hemodynamic parameters in patients with VDD pacemakers.

Authors:  Konstantin A Krychtiuk; Michael Nürnberg; Romana Volker; Linda Pachinger; Rudolf Jarai; Matthias K Freynhofer; Johann Wojta; Kurt Huber; Thomas W Weiss
Journal:  Wien Klin Wochenschr       Date:  2014-03-21       Impact factor: 1.704

2.  Refractory hypertensive emergency associated with complete heart block resolved after permanent pacemaker implantation: A case report.

Authors:  Moinuddin Choudhury; Narendra Kumar; Shajil Chalil; Khalid Abozguia
Journal:  Clin Case Rep       Date:  2022-06-19

3.  A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy.

Authors:  Andreas Kyriacou; Matthew E Li Kam Wa; Punam A Pabari; Beth Unsworth; Resham Baruah; Keith Willson; Nicholas S Peters; Prapa Kanagaratnam; Alun D Hughes; Jamil Mayet; Zachary I Whinnett; Darrel P Francis
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

4.  Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant.

Authors:  S M Afzal Sohaib; Andreas Kyriacou; Siana Jones; Charlotte H Manisty; Jamil Mayet; Prapa Kanagaratnam; Nicholas S Peters; Alun D Hughes; Zachary I Whinnett; Darrel P Francis
Journal:  Europace       Date:  2015-04-07       Impact factor: 5.214

5.  Pacemaker-Mediated Programmable Hypertension Control Therapy.

Authors:  Petr Neuzil; Béla Merkely; Andrejs Erglis; Germanas Marinskis; Joris R de Groot; Herwig Schmidinger; Manuel Rodriguez Venegas; Michiel Voskuil; Thomas Sturmberger; Jan Petru; Niels Jongejan; Josef Aichinger; Ginta Kamzola; Audrius Aidietis; Laszlo Gellér; Tomas Mraz; Istvan Osztheimer; Yuval Mika; Steven Evans; Daniel Burkhoff; Karl-Heinz Kuck
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

6.  Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function.

Authors:  Siana Jones; Joost Lumens; S M Afzal Sohaib; Judith A Finegold; Prapa Kanagaratnam; Mark Tanner; Edward Duncan; Philip Moore; Francisco Leyva; Mike Frenneaux; Mark Mason; Alun D Hughes; Darrel P Francis; Zachary I Whinnett
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

7.  His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.

Authors:  Ahran D Arnold; Matthew J Shun-Shin; Daniel Keene; James P Howard; S M Afzal Sohaib; Ian J Wright; Graham D Cole; Norman A Qureshi; David C Lefroy; Michael Koa-Wing; Nick W F Linton; Phang Boon Lim; Nicholas S Peters; D Wyn Davies; Amal Muthumala; Mark Tanner; Kenneth A Ellenbogen; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett
Journal:  J Am Coll Cardiol       Date:  2018-12-18       Impact factor: 24.094

8.  Pathophysiology of dyssynchrony: of squirrels and broken bones.

Authors:  R F Wiegerinck; R Schreurs; F W Prinzen
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

9.  British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints.

Authors:  Zachary I Whinnett; S M Afzal Sohaib; Siana Jones; Andreas Kyriacou; Katherine March; Emma Coady; Jamil Mayet; Alun D Hughes; Michael Frenneaux; Darrel P Francis
Journal:  BMC Cardiovasc Disord       Date:  2014-04-03       Impact factor: 2.298

10.  Comparison of different invasive hemodynamic methods for AV delay optimization in patients with cardiac resynchronization therapy: implications for clinical trial design and clinical practice.

Authors:  Zachary I Whinnett; Darrel P Francis; Arnaud Denis; Keith Willson; Patrizio Pascale; Irene van Geldorp; Maxime De Guillebon; Sylvain Ploux; Kenneth Ellenbogen; Michel Haïssaguerre; Philippe Ritter; Pierre Bordachar
Journal:  Int J Cardiol       Date:  2013-03-05       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.